Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Wellington researchers seek emphysema patients for study

Wellington researchers seek patients aged 40 and over with chronic bronchitis or emphysema for worldwide study


New Zealanders who suffer from chronic obstructive pulmonary disorder (COPD) – which is also known as “chronic bronchitis,” “smoker’s cough” or emphysema - are being encouraged to participate in a worldwide study that will test a potential new treatment for the condition.

Wellington researchers at P3 Research Wellington and the Medical Research Institute of New Zealand are joining forces with colleagues around the world to determine whether a potential new treatment can reduce the frequency of COPD symptoms, keep participants out of hospital and help them better cope with their day-to-day life.

Patients are being sought who:

- Are aged 40+

- Have COPD, chronic bronchitis, smoker’s cough, or emphysema and are taking regular medication for the condition

- Had some worsening in the last 12 months of COPD symptoms that required additional treatment or hospital admission

COPD has a substantial impact on the health of New Zealanders. Although often undiagnosed, it affects an estimated 15 percent of the adult population over the age of 45 years (at least 200 000 New Zealanders).1

Respiratory expert Dr Dean Quinn from P3 Research Wellington welcomed the study and said he hoped New Zealand patients would take the opportunity to participate.

“There is no cure for COPD which is why it is so important to keep researching new treatment options. We need treatments that do an effective job in reducing symptoms, keep people out of hospital and improve their quality of life,” said Dr Quinn.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

“Participating in a research study can also be beneficial for the participants as they receive high quality medical monitoring and regular health checks at no cost. The patients could do some good for themselves while also helping progress New Zealand research into new medicines,” concluded Dr Quinn.

Participation in the study is voluntary and information is kept strictly confidential. This study has been approved by Human Research Ethics Committees to be conducted at various New Zealand centres.

For further information about COPD and upcoming clinical trials you can call 0800 827 840 or visit www.gsk.co.nz/COPD

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.